疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

7 D% H8 t2 \" R$ k

Vaccines, 6th Edition

0 c! C4 W3 L$ x: _$ P8 BApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
2 F7 [- h5 K( N" ?% m9 q  i
. K7 L" i* I" b$ q. mhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
$ y. _; Y2 r- N/ l0 X
7 q7 X2 o+ ?, r, n$ @" }SECTION 1: General aspects of vaccination
4 F& t5 ?; i/ Y6 o0 G5 {0 [1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
: e. I( S, M4 l; s" P6 v7 Jlicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
2 j' X4 D1 K. a9 c9 O6 XSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
1 q" l! S- I8 M: N% P# e10 Anthrax vaccines 127
) o* b" W( n9 Y11 Cholera vaccines 141
12 Diphtheria toxoid 153
# v# d+ U4 M, o( r7 C13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
/ ^! X; A% x' p7 U; P16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
, e; k0 O* @6 X' S2 U, D, C19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
+ S! f8 N, x! _, H" z1 d21 Meningococcal vaccines 388
8 s+ N" G% `$ y% Y0 r22 Mumps vaccine 419
23 Pertussis vaccines . 447
; ]/ R: j. B+ B( X( N4 X/ i2 X( E24 Plague vaccines 493
( ^. n9 U, u& j8 [25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
; V. g1 x( p% O; G( f27 Poliovirus vaccine-inactivated . 573
+ W+ r5 L# [$ O  r% |: J28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
& d* D# V7 y% c" Q1 D8 m30 Rotavirus vaccines . 669
* l! ~# C$ q$ f5 G1 O8 f31 Rubella vaccine 688
4 c7 L" ~: K6 H. P! n3 B32 Smallpox and vaccinia 718
6 Z) H" h& `" a33 Tetanus toxoid 746
% e6 `$ o8 B( c. C34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
. z$ f1 h" k9 W36 Typhoid fever vaccines 812
37 Varicella vaccine 837
6 e) p: W# U7 |, M! z# {" C38 Yellow fever vaccine 870
" j7 b" n3 T9 W# y- ^39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
$ j* y* T; R- U2 q41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
& X$ H1 T2 z+ I7 \43 Cytomegalovirus vaccines 1032
+ ^5 N! v9 L  p0 Y% G% _44 Dengue vaccines 1042
$ P( q: v/ D2 ~  {5 c/ J4 D7 b45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
" P  F$ j9 v8 j47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
8 x# C; u. d  l7 s# n! Y/ B$ {49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
2 V; v" z7 R' f+ g: T0 _6 {& i51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
3 j$ G, P' X: }6 C) |53 Malaria vaccines 1133
0 F* v2 Q% g! j( J54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
( x# Q# P6 p, y59 Streptococcus group B vaccines 1176
  a, Y/ N# `# k! T# v60 Technologies for making new vaccines 1182
5 E% Y4 m6 j& Q! P4 w, s61 Alternative vaccine delivery methods 1200
" t6 K. D, y2 t8 A62 The development of gene-based vectors for immunization 1232
6 T5 K' X5 V& x' XSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
) V+ _4 C' w. C3 \64 Vaccination of human immunodeficiency virus-infected persons 1257
1 I- H: {8 y0 d1 Z$ o$ M) Y; i65 Vaccines for international travel 1270
9 j6 ?; o% y7 \$ D2 y. z) w66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
, O1 \9 L  `5 b67 Immunization in the United States 1310
6 s& j% P$ Y/ P. Z! n  C) `; Z68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
) W9 @0 Z, x" G4 q7 R6 }" a72 Economic analyses of vaccine policies 1413
( I# c0 J/ `/ p8 R& V0 |& Y- f73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
: }9 T  l( W2 w6 m8 f+ @  N9 b75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
# z' O# }9 u* \) Y$ L) z78 Ethics 1508




! d! g$ U# X4 ~% Y1 v

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

& ^$ i* x. C9 X# D+ `: Q: JVaccines, 6th Edition

( z+ I& N: G" C* ^Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
+ i: _& I& q$ x! G7 i7 Y; A* d
5 O( \& }% _$ G$ q+ c/ G) l. |http://yun.baidu.com/share/link? ... 1&uk=3810996606

3 ^/ @* M( U& @" I- s6 mSECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
. G. Z( f6 F. Q$ B& Z+ _& b3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
3 k6 J8 W/ E3 Q1 Y- }% F, O) ?7 Passive immunization 80
& H3 }! v( `& A0 W+ w, b8 General immunization practices 88
SECTION 2: Licensed vaccines
& N7 r& K0 G% ]$ |; |9 v2 `6 g9 Adenovirus vaccines 113
8 u8 W" J6 D) _10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
- {2 [+ [" E$ m% R" k6 v" C; B8 Q14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
+ l2 _. I$ `" }( N0 l4 t, r17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
. g& O6 O4 M0 V7 f( }  ^19 Japanese encephalitis vaccines 312
# E1 F% r+ h( k& |. ?1 m20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
; a* p  C) F5 H( {7 [. Y23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
/ a) `2 d, G9 e/ o26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
( @1 K: @' U2 g& N/ g$ k30 Rotavirus vaccines . 669
/ z- y) t9 {, O1 A/ ~/ z# j4 B31 Rubella vaccine 688
( u' N7 I) v& d0 o& u  {32 Smallpox and vaccinia 718
6 `; D3 D0 ?) \/ q; h% p+ K" H33 Tetanus toxoid 746
- f6 U" w) O" f# K34 Tick-borne encephalitis virus vaccines 773
2 P9 a' B2 w+ K3 U35 Tuberculosis vaccines 789
" Y/ d% `3 ~( L+ Q36 Typhoid fever vaccines 812
2 l2 a' O9 |4 A! ?! L  Y37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
0 D+ w* V2 n$ J40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
! H' d, H9 G8 }; e: n( {  Y) G43 Cytomegalovirus vaccines 1032
( [6 U$ c6 F( Q- C$ x7 j$ t8 i44 Dengue vaccines 1042
( E$ R0 J* o1 }45 Diarrhea caused by bacteria 1052
- F* V2 I9 Q+ ~, s% |% g46 Ebola vaccine 1060
5 l; K" r7 l% n# _  p* o: b47 Epstein-Barr virus vaccines 1068
: `4 Q% p9 S+ F: J+ S48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
# ?1 ?; P6 @/ T4 x4 c50 Herpes simplex virus vaccines 1090
# C2 I/ ~& n& D51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
/ f$ @7 \) }& V. u: M53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
: @, o+ g7 o9 Y1 o% ?$ b: C4 P, o: q# K58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
& ]9 F" P& \+ `0 y1 x; r( u63 Vaccination of immunocompromised hosts 1243
' A* q$ l; N! l% D) t64 Vaccination of human immunodeficiency virus-infected persons 1257
# |; N' g& F) S3 {! `$ F6 O( l3 b65 Vaccines for international travel 1270
2 |" ?8 ]5 F( O% t0 e# t) f66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
& s1 a5 d- |% ^! F67 Immunization in the United States 1310
68 Immunization in Europe . 1334
+ x* h3 p& H5 Z, h1 b; D* T69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
6 h' j( {& P- r. [73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
+ i' K7 |* h, b8 w* R  Z75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508

  E4 c- e. @6 A& K3 Z7 ^
. a6 Y. V/ \' w7 _/ i

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
, G" h; f8 V  T) N% M8 V& c+ hPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
( n; R: m8 Q; pISBN-10: 1455700908
/ M( z/ `: K, nSize: 52.3mb (original pdf)
5 Q3 \9 j+ f; H( T* E
2013 BMA Medical Book Awards Highly Commended in Public Health!
* N1 x& c* ~, a/ pApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

% L8 q7 d, w' V, E- WGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
" y* }$ @; n4 }Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
* n/ h5 J; ~/ Y: X( FAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
1 Y1 w6 D0 R3 V- t0 TMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
1 y% }& [( }1 B. x: T7 {Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

" x5 C' t* o. t( gDownload link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96
) ?. v& s& p) C* c